Roche Farma, S.A. secures contract for VARIOUS MEDICINAL PRODUCTS - SUPPLY OF ACTIVE PRINCIPLES called "FARICIMAB 28.8 MG / 0.24 ML VIAL 0.24 ML INTRAVITREA" AND "POLATUZUMAB VEDOTINA 30MG PERIOD PERFUSION"

Spain, March 10 -- Spain based Roche Farma, S.A. has secured contract from Direccion Gerencia Hospital Universitario de Gran Canaria Doctor Negrin for VARIOUS MEDICINAL PRODUCTS - SUPPLY OF ACTIVE PRINCIPLES called "FARICIMAB 28.8 MG / 0.24 ML VIAL 0.24 ML INTRAVITREA" AND "POLATUZUMAB VEDOTINA 30MG PERIOD PERFUSION". The value of the contract is worth 20135250 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....